597 related articles for article (PubMed ID: 16782922)
41. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
Simon JA;
Menopause; 2006; 13(2):222-31. PubMed ID: 16645536
[TBL] [Abstract][Full Text] [Related]
42. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study.
D'Anna R; Cannata ML; Atteritano M; Cancellieri F; Corrado F; Baviera G; Triolo O; Antico F; Gaudio A; Frisina N; Bitto A; Polito F; Minutoli L; Altavilla D; Marini H; Squadrito F
Menopause; 2007; 14(4):648-55. PubMed ID: 17251874
[TBL] [Abstract][Full Text] [Related]
43. Mayo Clinic and North Central Cancer Treatment Group hot flash studies: a 20-year experience.
Loprinzi CL; Barton DL; Sloan JA; Novotny PJ; Dakhil SR; Verdirame JD; Knutson WH; Kelaghan J; Christensen B
Menopause; 2008; 15(4 Pt 1):655-60. PubMed ID: 18427355
[TBL] [Abstract][Full Text] [Related]
44. Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety.
Archer DF; Dupont CM; Constantine GD; Pickar JH; Olivier S;
Am J Obstet Gynecol; 2009 Mar; 200(3):238.e1-238.e10. PubMed ID: 19167693
[TBL] [Abstract][Full Text] [Related]
45. Acupuncture for postmenopausal hot flashes.
Nir Y; Huang MI; Schnyer R; Chen B; Manber R
Maturitas; 2007 Apr; 56(4):383-95. PubMed ID: 17182200
[TBL] [Abstract][Full Text] [Related]
46. Confirmation of the efficacy of ERr 731 in perimenopausal women with menopausal symptoms.
Kaszkin-Bettag M; Ventskovskiy BM; Solskyy S; Beck S; Hasper I; Kravchenko A; Rettenberger R; Richardson A; Heger PW
Altern Ther Health Med; 2009; 15(1):24-34. PubMed ID: 19161045
[TBL] [Abstract][Full Text] [Related]
47. North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes.
Park H; Qin R; Smith TJ; Atherton PJ; Barton DL; Sturtz K; Dakhil SR; Anderson DM; Flynn K; Puttabasavaiah S; Le-Lindqwister NA; Padula GD; Loprinzi CL
Menopause; 2015 Jun; 22(6):627-32. PubMed ID: 25423327
[TBL] [Abstract][Full Text] [Related]
48. Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial.
Butt DA; Lock M; Lewis JE; Ross S; Moineddin R
Menopause; 2008; 15(2):310-8. PubMed ID: 17917611
[TBL] [Abstract][Full Text] [Related]
49. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer.
Jacobson JS; Troxel AB; Evans J; Klaus L; Vahdat L; Kinne D; Lo KM; Moore A; Rosenman PJ; Kaufman EL; Neugut AI; Grann VR
J Clin Oncol; 2001 May; 19(10):2739-45. PubMed ID: 11352967
[TBL] [Abstract][Full Text] [Related]
50. A 12-week clinical trial determining the efficacy of synthetic conjugated estrogens, A (SCE), in the treatment of vasomotor symptoms in menopausal women.
Stevens RE; Hanford K; Wason S; Cusack SL; Phelps KV
Int J Fertil Womens Med; 2000; 45(4):264-72. PubMed ID: 10997482
[TBL] [Abstract][Full Text] [Related]
51. Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract.
Naser B; Schnitker J; Minkin MJ; de Arriba SG; Nolte KU; Osmers R
Menopause; 2011 Apr; 18(4):366-75. PubMed ID: 21228727
[TBL] [Abstract][Full Text] [Related]
52. A randomized double-blind placebo-controlled trial of a Chinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women.
Xia Y; Zhao Y; Ren M; Zhang J; Wang Y; Chang Y; Fu S; Fan G; Zhu Y; Huang Y; Gao X
Menopause; 2012 Feb; 19(2):234-44. PubMed ID: 22089177
[TBL] [Abstract][Full Text] [Related]
53. Phyto-Female Complex for the relief of hot flushes, night sweats and quality of sleep: randomized, controlled, double-blind pilot study.
Rotem C; Kaplan B
Gynecol Endocrinol; 2007 Feb; 23(2):117-22. PubMed ID: 17454163
[TBL] [Abstract][Full Text] [Related]
54. Pomegranate seed oil in women with menopausal symptoms: a prospective randomized, placebo-controlled, double-blinded trial.
Auerbach L; Rakus J; Bauer C; Gerner C; Ullmann R; Wimmer H; Huber J
Menopause; 2012 Apr; 19(4):426-32. PubMed ID: 22240636
[TBL] [Abstract][Full Text] [Related]
55. A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause.
Archer DF; Seidman L; Constantine GD; Pickar JH; Olivier S
Am J Obstet Gynecol; 2009 Feb; 200(2):172.e1-10. PubMed ID: 19110224
[TBL] [Abstract][Full Text] [Related]
56. Black cohosh: an alternative therapy for menopause?
Mahady GB; Fabricant D; Chadwick LR; Dietz B
Nutr Clin Care; 2002; 5(6):283-9. PubMed ID: 12557811
[TBL] [Abstract][Full Text] [Related]
57. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial.
Pandya KJ; Morrow GR; Roscoe JA; Zhao H; Hickok JT; Pajon E; Sweeney TJ; Banerjee TK; Flynn PJ
Lancet; 2005 Sep 3-9; 366(9488):818-24. PubMed ID: 16139656
[TBL] [Abstract][Full Text] [Related]
58. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial.
Tice JA; Ettinger B; Ensrud K; Wallace R; Blackwell T; Cummings SR
JAMA; 2003 Jul; 290(2):207-14. PubMed ID: 12851275
[TBL] [Abstract][Full Text] [Related]
59. Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study.
Nahas EA; Nahas-Neto J; Orsatti FL; Carvalho EP; Oliveira ML; Dias R
Maturitas; 2007 Nov; 58(3):249-58. PubMed ID: 17913408
[TBL] [Abstract][Full Text] [Related]
60. Newer antidepressants for hot flashes--should their efficacy still be up for debate?
Loprinzi CL; Barton DL; Sloan JA; Novotny PJ; Wolf S
Menopause; 2009; 16(1):184-7. PubMed ID: 18725865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
